Use and cost comparison of clobazam to other antiepileptic drugs for treatment of Lennox-Gastaut syndrome
Background: Lennox-Gastaut syndrome (LGS) is a severe form of childhood-onset epilepsy associated with serious injuries due to frequent and severe seizures. Of the antiepileptic drugs (AEDs) approved for LGS, clobazam is a more recent market entrant, having been approved in October 2011. Recent AED...
I tiakina i:
| Ngā kaituhi matua: | , , , , , , , |
|---|---|
| Hōputu: | Artigo |
| Reo: | Inglês |
| I whakaputaina: |
MDPI AG
2017-01-01
|
| Rangatū: | Journal of Market Access & Health Policy |
| Ngā marau: | |
| Urunga tuihono: | http://dx.doi.org/10.1080/20016689.2017.1318691 |
| Ngā Tūtohu: |
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|